Antibodies that bind to mammalian NGAL and uses thereof
US8846036B2 · kind B2 · utility
3Cited by
6References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 2008 |
| Grant date | Sep 30, 2014 |
| Priority date | — |
| Expiry date | Jan 29, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies specific for glycosylated mammalian NGAL, and to methods of making and using such antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.